LOS ANGELES, CA, May 27, 2026 /24-7PressRelease/ -- Four groundbreaking startups have been officially selected from a pool of highly qualified applicants to present their live Regulation Crowdfunding (Reg CF) offerings at the upcoming Superpowers for Good Live Pitch. The highly anticipated event will broadcast live on June 3 at 8:00 PM Eastern on the e360tv Network, accessible via Roku, Amazon Fire TV, Apple TV, and a variety of other smart TV platforms.

The Superpowers for Good Live Pitch connects retail and accredited investors with visionary companies dedicated to driving profound social and environmental impact. The show is produced by The Super Crowd, Inc., a Delaware-based public benefit corporation, and is hosted by the company's CEO, Devin Thorpe. Following rigorous scrutiny and screening by a distinguished panel of professional investors, the four companies selected to pitch are SenoGuard, Eisana Health, Rejuvenate Bio, and Emission Free Generators.

"I couldn't be more thrilled with the judges' selection of these four outstanding companies," said Thorpe regarding the final lineup. "The groundbreaking work they are doing in healthcare and clean technology represents exactly the kind of impact we strive to showcase. We had a massive pool of highly qualified applicants this year, and while it is sadly true that many great companies couldn't be included, these four finalists truly stand out for their potential to change the world."

"I am incredibly excited for this live pitch event," Thorpe added. "It is going to be fascinating to watch our expert judges at work as they pressure-test these offerings in real-time on the broadcast. Their deep industry knowledge and rigorous screening process will give our audience a transparent, educational look into exactly how top-tier investors evaluate Reg CF deals."

The event will feature live pitches from the executives driving these companies forward: Diana Tucker, CEO of SenoGuard; Carole Spangler Vaughn, CEO of Eisana Health; Daniel Oliver, CEO of Rejuvenate Bio; and Mark Collins, CEO of Emission Free Generators.

The Expert Judging Panel

The four finalists were selected after extensive vetting by three of the crowdfunding industry's most respected voices: Sherwood "Woodie" Neiss, Teddy Lyons, and Paul Lovejoy. Woodie and Teddy both help to manage funds that invest actively in Reg CF deals, utilizing robust data analytics and profound market experience. Paul Lovejoy is a Registered Investment Advisor (RIA) who is personally active in investing via Reg CF and advises his clients on building portfolios centered on community capital and impact.

As three of the selected companies operate in the healthcare and biotech spaces, the judges applied intense scrutiny to ensure the viability and potential of the medical innovations.

"When examining early-stage healthcare offerings like SenoGuard, Eisana Health, and Rejuvenate Bio in the Reg CF space, our screening prioritizes companies that pair profound scientific innovation with a clear, data-backed path to regulatory approval and commercialization," said Sherwood Neiss. "We look at the founders' track records and the foundational IP to ensure these medical breakthroughs can successfully transition from the lab to the patients who desperately need them."

Paul Lovejoy emphasized the stakeholder impact: "Investing in healthcare is fundamentally about investing in human thriving. When I conduct due diligence on health offerings, I'm looking for solutions that address massive, unmet needs—like mitigating the devastating side effects of chemotherapy or addressing root-cause aging. I want to see companies that treat patients as stakeholders and strive to democratize health outcomes for everyone."

The fourth company, Emission Free Generators, operates in the clean technology sector, presenting a different set of evaluation metrics for the judges.

"Evaluating clean tech companies such as Emission Free Generators requires a rigorous look at the scalability and economic viability of the technology," Neiss explained. "We want to see more than just environmental benefits; we need to see a business model—like their cartridge-based hydrogen-on-demand system—that makes emission-free energy accessible, affordable, and highly practical for the everyday consumer while delivering strong profit margins."

Lyons noted the importance of execution in hardware: "In the clean tech sector, it's all about execution and defensible technology. When evaluating hardware like Emission Free Generators, I dig into the supply chain, the unit economics, and third-party validation. Seeing over 10,000 hours of testing and strategic grants provides the empirical evidence we require to confidently present an opportunity to our investor community."

Lovejoy highlighted the community resilience aspect: "When I look at clean technology, my focus is on building sustainable, alternative economic infrastructure. An offering like Emission Free Generators represents community resilience; it empowers individuals to generate their own safe, emission-free power indoors during emergencies. My evaluation centers on how perfectly the technology aligns with creating a decentralized, sustainable future that protects our communities from an aging, vulnerable grid."

The Selected Companies and Offerings

The four companies selected to pitch all have active Reg CF campaigns, allowing viewers to invest directly during and after the broadcast.

SenoGuard, Inc.
SenoGuard, based in Seal Beach, California, is an early-stage medical device company focused on developing innovative healthcare solutions. Under the leadership of CEO Diana Tucker, SenoGuard plans to continue product research, expand patent protection, and advance product development. As the company navigates the rigorous FDA approval processes and scaling challenges inherent in the medical device industry, the current funding round is designed to propel their prototype through vital developmental milestones.

Eisana Corp. (Eisana Health)
Headquartered in The Woodlands, Texas, Eisana Health is developing a groundbreaking medical cooling device specifically designed to prevent chemotherapy-induced peripheral neuropathy—a debilitating side effect experienced by countless cancer patients. Led by CEO Carole Spangler Vaughn, will engineer the product for manufacturing and conduct necessary clinical studies. By targeting a severe unmet need in the oncology space, Eisana Health aims to improve the quality of life for patients undergoing rigorous cancer treatments, positioning itself as a vital preventive tool in modern healthcare.

Rejuvenate Bio, Inc.
San Diego-based Rejuvenate Bio is a biotechnology company developing revolutionary one-shot gene therapies designed to treat chronic, age-related diseases in both companion animals and humans. Spun out of George Church's lab at Harvard Medical School, the company utilizes adeno-associated virus (AAV) delivery systems to modulate genetic pathways to restore youthful metabolic and cardiac function. Led by CEO Daniel Oliver, Rejuvenate Bio has already secured over $130 million in contracted development and commercial milestone payments across multiple animal health partnerships, and features a proprietary manufacturing system capable of producing doses for under $100. The company will continue clinical trials, targeting devastating conditions like mitral valve disease and osteoarthritis in dogs as a precursor to human therapeutics.

Emission Free Generators, Inc.
Emission Free Generators (EFG), operating out of Delaware and California, has developed the ZenH2—a groundbreaking, portable, hydrogen-on-demand generator. Helmed by CEO Mark Collins, EFG has created a system that uses a proprietary, mail-safe $6.45 powder cartridge and tap water to generate clean electricity safely indoors. The technology is designed to provide life-saving backup power for the 127 million Americans who cannot safely operate traditional gas generators, including apartment dwellers and those reliant on medical devices. Having already completed over 10,000 hours of rigorous testing and secured grants from organizations like SoCal Gas, EFG is utilizing a "razor and blade" recurring revenue model. The company is working to complete UL certification and initiate its first major production run in 2026, strategically timing its launch ahead of California's impending ban on gas-powered generators.

Event Information
Investors, industry professionals, and the general public are encouraged to tune in to the Superpowers for Good Live Pitch on June 3 at 8:00 PM Eastern. The program will be broadcast on the e360tv Network, which can be downloaded on Roku, Amazon Fire TV, Apple TV, and Android TV.

Immediately following the televised pitch, attendees will be provided with a link to join a private Zoom meeting. This exclusive post-show session will feature breakout rooms with Diana Tucker, Carole Spangler Vaughn, Daniel Oliver, and Mark Collins, offering prospective investors the rare opportunity to speak face-to-face with the founders, ask specific due diligence questions, and learn more about each company's Reg CF offering.

About The Super Crowd, Inc.
The Super Crowd, Inc., a public benefit corporation, produces media, events and educational programming that help social entrepreneurs, community builders and purpose-driven founders access capital and build stronger communities. Through Superpowers for Good, SuperCrowd events and related initiatives, The Super Crowd, Inc. works to make impact investing and impact crowdfunding more accessible, credible and effective. Learn more at TheSuperCrowd.com.

# # #